Science Explorer Interactive view Map
Company · Anagni · Italy

Bristol-Myers Squibb (Italy)

bms.comROR OpenAlex
Research works
66
▼ 34% vs 2013–17
Citations
1.3k
19.1 per fractional work
Top-10% rate
14.1%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: Bristol-Myers Squibb (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.02× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 2.15× its world share, 0 worksImmunology and Micro…Neuroscience: 1.31× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.27× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.41× its world share, 0 worksChemistryComputer Science: 1.25× its world share, 1 worksComputer ScienceHealth Professions: 0.33× its world share, 0 worksHealth ProfessionsMedicine: 3.02× its world share, 8 worksMedicineBusiness, Management and Accounting: 0.15× its world share, 0 worksBusiness, Management…Decision Sciences: 2.65× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 7.86× its world share, 2 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 7.9×. Every wedge is a field page.

Which keywords describe research at Bristol-Myers Squibb (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Chemotherapy, Clinical Trials, Cardiovascular Disease, Clinical Guidelines, Cost-effectiveness Analysis, Health Utility Measures and Treatment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life5▲ 6.0×10 topics
  2. Epidemiology4▲ 1.69×21 topics
  3. Chemotherapy4▲ 9.4×13 topics
  4. Clinical Trials4▲ 10×9 topics
  5. Inflammation4▲ 2.6×16 topics
  6. Cardiovascular Disease4▲ 5.4×16 topics
  7. Treatment4▲ 4.6×11 topics
  8. Clinical Guidelines3▲ 16×6 topics
  9. Cost-effectiveness Analysis3▲ 64×1 topic
  10. Health Utility Measures3▲ 64×1 topic
  11. Risk Factors3▲ 4.7×8 topics
  12. Guidelines3▲ 9.7×7 topics
  13. Cardiovascular Events3▲ 26×4 topics
  14. Hypertension3▲ 12×5 topics
  15. Catheter Ablation3▲ 34×2 topics
  16. Immune Response3▲ 6.3×7 topics
  17. Global Burden2▲ 7.0×4 topics
  18. Prognostic Factors2▲ 8.4×8 topics
  19. Targeted Therapy2▲ 18×2 topics
  20. Immunotherapy2▲ 5.3×11 topics
  21. Pharmaceutical Industry2▲ 87×2 topics
  22. Stroke Prevention2▲ 28×2 topics
  23. Anticoagulant Therapy2▲ 29×1 topic
  24. Atrial Fibrillation2▲ 36×1 topic
  25. Adverse Drug Reactions2▲ 48×2 topics
  26. Blood Pressure2▲ 45×2 topics
  27. Data Mining2▲ 7.0×2 topics
  28. Treatment Guidelines2▲ 15×3 topics
  29. Antihypertensive Drugs2▲ 56×1 topic
  30. Drug Development Costs2▲ 118×1 topic
  31. Generic Drugs2▲ 118×1 topic
  32. Monoclonal Antibodies2▲ 21×2 topics
  33. Renal Denervation2▲ 56×1 topic
  34. ALK Inhibitors2▲ 52×1 topic
  35. Autoantibodies2▲ 12×4 topics
  36. Cardiovascular Risk2▲ 8.1×4 topics
  37. Clinical Outcomes2▲ 14×2 topics
  38. EGFR Mutations2▲ 52×1 topic
  39. Genomic Profiling2▲ 29×2 topics
  40. Rituximab2▲ 18×2 topics

Which research topics does Bristol-Myers Squibb (Italy) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Explainable Artificial Intelligence (XAI), Economic and Financial Impacts of Cancer and Lung Cancer Treatments and Mutations.

Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksExplainable Artificial Intelligence (XAI): 1 fractional worksEconomic and Financial I…1Economic and Financial Impacts of Cancer: 1 fractional worksLung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksArtificial Intelligence in Healthcare and Education: 0 fractional worksLung Cancer Diagnosis an…0Lung Cancer Diagnosis and Treatment: 0 fractional worksTopic Modeling0Topic Modeling: 0 fractional worksStock Market Forecasting Methods: 0 fractional worksAcute Myeloid Leukemia Research: 0 fractional works
Economics and EconometricsArtificial IntelligencePulmonary and Respiratory MedicineOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  2. 2 Explainable Artificial Intelligence (XAI) Artificial Intelligence 1 works
  3. 3 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
  6. 6 Artificial Intelligence in Healthcare and Education Health Informatics 0 works
  7. 7 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  8. 8 Topic Modeling Artificial Intelligence 0 works
  9. 9 Stock Market Forecasting Methods Management Science and Operations Research 0 works
  10. 10 Acute Myeloid Leukemia Research Hematology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.3%not open50.7%

World: 28% of research is openly available.

with international co-authors51.9%domestic only48.1%

World: 19% is written across borders.

How has Bristol-Myers Squibb (Italy)'s research output changed?

Output in 2018–2022 was 34% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.